Cure My Disease

Don't miss your cure!

 Log in / Sign up

JAGUAR trial: ObJective analysis to GaUge EVAR outcomes through randomization

NCT ID NCT05064540

NEW Sponsor: Endologix Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now This study
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Sep 09, 2026 · Last updated Sep 09, 2026

Summary

Prospective, randomized, multi-center study designed to evaluate the outcomes of commercially available contemporary EVAR in a real-world population. Patients will be randomized into two device cohorts and compared across the primary endpoints. Patients will be followed procedurally to discharge, at 1, 6, 12 months and annually through to 5 years (total follow-up commitment).

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

About 450 people

The number the study aims to enrol. It can still change while the study runs.

Started

Sep 2021

Expected to finish

Mar 2032

An estimate. End dates often move.

Lead sponsor

A company

The lead sponsor is a pharmaceutical, biotech, or medical-device company.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

21 years and older

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Adult age 21 and older * Subjects with minimum of 2 year life expectancy * Subjects have signed the informed consent document * Subjects with unruptured infrarenal AAA who are assessed by the Investigator to be eligible for endovascular Abdominal Aortic Aneurysm Repair with the trial devices. * Patient must be able and willing to comply with all required follow-up exams. Exclusion Criteria: * Currently participating in another trial where the primary endpoint has not been reached yet. * Known allergy to any of the device components * Pregnant (females of childbearing potential only) * Known connective tissue disorders * Known active infection * Subjects with pre-existing EVAR, i.e., in need of repair/intervention of a previously failed EVAR. * Patient has other medical, social, or psychological conditions that, in the opinion of the investigator, preclude them from receiving the pre-treatment, required treatment, and post-treatment procedures and evaluations.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for AAA are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

abdominal aortic aneurysm triple-A syndrome

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

AAA Aaa - abdominal aortic aneurysm

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    25 sites. The list below names each one and where it is.

  2. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • Allegheny Health Network

    RECRUITING

    Pittsburgh, Pennsylvania, 15212, United States

  • Baptist Hospital of Miami, Miami Cardiac and Vascular Institute

    RECRUITING

    Miami, Florida, 33176, United States

  • Central Arkansas Veterans Healthcare System

    RECRUITING

    Little Rock, Arkansas, 72205, United States

  • Feinstein Institutes for Medical Research (Staten Island University Hospital/Northwell Health)

    RECRUITING

    Staten Island, New York, 10305, United States

  • Henry Ford Hospital

    WITHDRAWN

    Detroit, Michigan, 48202, United States

  • Houston Methodist Research Institute

    RECRUITING

    Houston, Texas, 77030, United States

  • Huntsville Hospital

    ACTIVE_NOT_RECRUITING

    Huntsville, Alabama, 35801, United States

  • Icahn School of Medicine at Mount Sinai

    RECRUITING

    New York, New York, 10029-6574, United States

  • Jacksonville Center for Clinical Research

    RECRUITING

    Jacksonville, Florida, 32216, United States

  • Lehigh Valley Health Network

    RECRUITING

    Allentown, Pennsylvania, 18103, United States

  • MedStar Washington Hospital Center

    RECRUITING

    Washington D.C., District of Columbia, 20001, United States

  • Newark Beth Israel Medical Center

    RECRUITING

    Newark, New Jersey, 07112, United States

  • Oregon Health Sciences University

    RECRUITING

    Portland, Oregon, 97239, United States

  • Radiology and Imaging Specialists

    RECRUITING

    Lakeland, Florida, 33801, United States

  • Sentara Hospitals

    RECRUITING

    Norfolk, Virginia, 23507, United States

  • The Cleveland Clinical Foundation

    RECRUITING

    Cleveland, Ohio, 44106, United States

  • The Ohio State University

    WITHDRAWN

    Columbus, Ohio, 43210, United States

  • The Regents of the University of California, San Diego

    RECRUITING

    La Jolla, California, 92093, United States

  • The University of Texas Medical Branch at Galveston

    RECRUITING

    Galveston, Texas, 77555, United States

  • Tufts Medical Center

    RECRUITING

    Boston, Massachusetts, 02111, United States

  • U.S. Department of Veterans Affairs, VA Portland Health Care System

    RECRUITING

    Portland, Oregon, 97239, United States

  • University of Arizona

    RECRUITING

    Tucson, Arizona, 85716, United States

  • University of Iowa Hospitals and Clinics

    ACTIVE_NOT_RECRUITING

    Iowa City, Iowa, 52242, United States

  • University of Louisville

    RECRUITING

    Louisville, Kentucky, 40202-1959, United States

  • University of Missouri

    RECRUITING

    Columbia, Missouri, 65212, United States

  • University of Pennsylvania

    RECRUITING

    Philadelphia, Pennsylvania, 19104, United States

  • Veterans Affairs San Diego Healthcare System

    RECRUITING

    San Diego, California, 92161, United States

  • Washington Regional Medical Center

    RECRUITING

    Fayetteville, Arkansas, 72703, United States

  • Wellmont Cardiology Services

    RECRUITING

    Kingsport, Tennessee, 37660, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.